All Posts
Germans embrace fresh air to ward off coronavirus
2 Oct, 2020 | 09:18h | UTCGermans embrace fresh air to ward off coronavirus – The Guardian
Medication related hospital admissions and readmissions in older patients: an overview of literature
2 Oct, 2020 | 09:15h | UTC
India pushes bold ‘one nation, one subscription’ journal-access plan
2 Oct, 2020 | 09:10h | UTCIndia pushes bold ‘one nation, one subscription’ journal-access plan – Nature
Drug-related orthostatic hypotension: Beyond anti-hypertensive medications
2 Oct, 2020 | 09:13h | UTCDrug-Related Orthostatic Hypotension: Beyond Anti-Hypertensive Medications – Drugs & Aging
Commentary on Twitter
Drug-Related Orthostatic Hypotension: Beyond Anti-Hypertensive Medications. An open access review … https://t.co/YB0KiEiAtF pic.twitter.com/YzfsmQmtbZ
— Rohan Elliott (@elliott_rohan) September 30, 2020
Randomized trial: Hydroxychloroquine vs. placebo for pre-exposure SARS-CoV-2 prophylaxis among health care workers
1 Oct, 2020 | 09:17h | UTCCommentary: Hydroxychloroquine didn’t prevent COVID-19 among health care workers in new study – CNN
Commentary on Twitter
#Hydroxychloroquine taken daily by hospital-based health care providers over 8 weeks did not prevent #SARSCoV2 infection, in a double-blind randomized placebo-controlled trial performed at 2 University of Pennsylvania hospitals https://t.co/7XHn6uBh4Z
— JAMA Internal Medicine (@JAMAInternalMed) September 30, 2020
HHMI, one of the largest research philanthropies, will require immediate open access to papers
2 Oct, 2020 | 09:09h | UTCRelated: UC Terminates Subscriptions with World’s Largest Scientific Publisher in Push for Open Access (several resources on the subject)
This overlooked variable is the key to the pandemic. It’s k, the dispersion factor, not R.
1 Oct, 2020 | 09:12h | UTCThis Overlooked Variable Is the Key to the Pandemic. It’s not R. – The Atlantic
Commentary on Twitter
It's k, the dispersion factor, not R. @zeynep's ★ synthesis of the opportunity to get ahead of the virus by taking advantage of the 80/20 rule for how it spreads, the avoidance of superspreading (not overlooked by me; a compelling case here)https://t.co/dZSHHdkOTA @TheAtlantic
— Eric Topol (@EricTopol) September 30, 2020
COVID has killed more than one million people. How many more will die?
1 Oct, 2020 | 09:13h | UTCCOVID has killed more than one million people. How many more will die? – Nature
Commentary on Twitter
Researchers warn that official figures underestimate the pandemic’s real death toll, which could more than triple if the virus is allowed to spread unchecked. https://t.co/H9hbI38ZEa
— Nature News & Comment (@NatureNews) September 30, 2020
Recommendations for antibacterial therapy in adults with COVID-19 – An evidence based guideline
1 Oct, 2020 | 09:15h | UTC
Commentary on Twitter
?Just published?@CMIJournal
Recommendations for antibacterial therapy in adults with COVID-19 – An evidence based guideline by the Dutch Working Party on Antibiotic Policy. #IDTwitter #COVID19 https://t.co/7cfZtS6Duv pic.twitter.com/Kz7CPMNLmh— Antibiotic Steward? Bassam Ghanem (@ABsteward) September 30, 2020
The evolving picture of SARS-CoV-2 and COVID-19 in children: critical knowledge gaps
1 Oct, 2020 | 09:09h | UTC
Commentary on Twitter
The evolving picture of SARS-CoV-2 and COVID-19 in children: critical knowledge gapshttps://t.co/vPWuNytBPP pic.twitter.com/pbLY1m9ZD2
— BMJ Global Health (@GlobalHealthBMJ) September 30, 2020
Audio interview: Covid-19 testing and the individual physician
1 Oct, 2020 | 09:11h | UTCAudio Interview: Covid-19 Testing and the Individual Physician – New England Journal of Medicine
Perspective: Rethinking Covid-19 test sensitivity — a strategy for containment
1 Oct, 2020 | 09:10h | UTCRethinking Covid-19 Test Sensitivity — A Strategy for Containment – New England Journal of Medicine
Keeping best practices in critical care during COVID-19
1 Oct, 2020 | 09:08h | UTCKeeping Best Practices in Critical Care During COVID-19 – ICU Management & Practice
Commentary on Twitter
COVID-19 poses several challenges and has made it difficult to measure ICU performance.
Read the article 'Keeping Best Practices in Critical Care During COVID-19' by @f_g_zampieri ?https://t.co/kvwlGSLBav#Covid19 #ICU #patientoutcome #FOAMcc #FOAMed pic.twitter.com/2YOhOnidxZ
— ICU Management (@ICU_Management) September 28, 2020
A systematic review and meta-analysis of published research data on COVID-19 infection-fatality rates
1 Oct, 2020 | 09:04h | UTC
Commentary on Twitter
(1/3) Excellent, rigorous review and meta-analysis of #COVID19 infection fatality ratio (IFR).
The overall IFR was 0.68% (95% CI 0.53-0.82%).
If only studies with a low risk of bias were included, the IFR rose to 0.76% (0.37-1.15%).https://t.co/F5GN0253lz https://t.co/7ucGgQ78AM pic.twitter.com/laHO3e4sl3
— Dr Zoë Hyde (@DrZoeHyde) September 30, 2020
Viewpoint: COVID-19 and heart failure with preserved ejection fraction
1 Oct, 2020 | 09:06h | UTCCOVID-19 and Heart Failure With Preserved Ejection Fraction – JAMA
New research shows older adults are still often excluded from clinical trials
1 Oct, 2020 | 09:02h | UTCNew research shows older adults are still often excluded from clinical trials – STAT
Original Study: The Exclusion of Older Persons From Vaccine and Treatment Trials for Coronavirus Disease 2019—Missing the Target – JAMA Internal Medicine
Commentary on Twitter
“It is important we have a trial population that reflects the real-world population." https://t.co/tRpo0NGL5x
— STAT (@statnews) October 1, 2020
[Abstract Only] Atezolizumab for first-line treatment of PD-L1–selected patients with non–small-cell lung cancer
1 Oct, 2020 | 08:53h | UTCCommentary: Atezolizumab Leads to Longer OS for Some Types of Advanced NSCLC, Study Says – AJMC
Invasive candidiasis in critical care: Challenges and future directions
1 Oct, 2020 | 09:00h | UTCInvasive candidiasis in critical care: challenges and future directions – Intensive Care Medicine
Commentary on Twitter
Invasive candidiasis: most common #ICU fungal infection ~40-55% mortality. Key challenges:
➡️ changing epidemiology/emergence of resistances
➡️ timely/appropriate therapy initiation/discontinuation
➡️ choosing/tailoring optimal antifungals#FOAMcc review https://t.co/tMPNcYfzwL pic.twitter.com/HvJKr0jX2o— Intens Care Med (@yourICM) September 30, 2020
Systematic review: The effectiveness and cost‐effectiveness of hospital‐based specialist palliative care for adults with advanced illness and their caregivers
1 Oct, 2020 | 08:58h | UTC
Commentary on Twitter
Cochrane review on hospital-based specialist palliative care. Findings: Improved HR-QoL and patient satisfaction, reduced symptom burden and depression, and increased chances of patients dying in their preferred place. @SBajwah @cochranecollab https://t.co/wjhGp0gcbs
— Olaf Geerse (@OlafGeerse) September 30, 2020
New COVID-19 inpatient risk calculator estimates the probability of severe disease or death at hospital admission
30 Sep, 2020 | 09:51h | UTCCommentaries: COVID-19 ‘prediction model’ uses data that can help determine if patients’ conditions are likely to worsen – Johns Hopkins Medicine AND Prediction model incorporates more than 20 variables at hospital admission – Physician’s Weekly AND Patient Trajectories Among COVID-19 Hospitalized Patients – American College of Cardiology
Interactive Calculator: The COVID Inpatient Risk Calculator: CIRC
Commentary on Twitter
Lead authors Brian T. Garibaldi, MD, MEHP and Jacob Fiksel, PhD of @HopkinsMedicine developed the COVID-19 Inpatient Risk Calculator (CIRC) that uses patient data at admission to determine potential disease trajectory for #COVID19.
Link: https://t.co/i1e1ek7wO7. @Bedsidemedicine pic.twitter.com/wQLctHHYrn
— Annals of Int Med (@AnnalsofIM) September 22, 2020
[Abstract Only] Nationwide cohort study in Sweden shows HPV vaccination linked to reduced risk of invasive cervical cancer
1 Oct, 2020 | 08:56h | UTCHPV Vaccination and the Risk of Invasive Cervical Cancer – New England Journal of Medicine
News Release: HPV vaccine effective against cervical cancer – Karolinska Institutet
Low risk of SARS-CoV-2 transmission by fomites in real-life conditions
30 Sep, 2020 | 09:48h | UTC
Commentary on Twitter
A reassuring note about lack of virus being cultured from surfaces, fomites, even in the hospital setting, pointing against this mode of transmission https://t.co/iMhzB6nvqQ @TheLancetInfDis pic.twitter.com/zJDuhc3BBC
— Eric Topol (@EricTopol) September 29, 2020
Proposed clinical criteria for COVID-19-associated hyperinflammatory syndrome
30 Sep, 2020 | 09:50h | UTC
Commentary on Twitter
Defining and grading the clinical hyperinflammatory syndrome with #COVID19 and how this cytokine storm relates to outcomes https://t.co/6Ngp3OHZJx @TheLancetRheum @Intermountain pic.twitter.com/bDGwKpjOI4
— Eric Topol (@EricTopol) September 29, 2020
Recent increase in COVID-19 cases reported among adults aged 18–22 years in the US
30 Sep, 2020 | 09:44h | UTCCommentary: CDC Documents Increase in Coronavirus Cases Among Young Adults – U.S.News
Commentary on Twitter
New @CDCMMWR shows #COVID19 infections among 18-22 year-olds increased more than 50% from early August to early Sept. Everyone needs to help slow the spread of COVID-19. Wear a mask, stay 6 feet from others, wash hands often, & stay home when sick. https://t.co/OLCkD1v23I pic.twitter.com/hu7R5QFlpb
— CDC (@CDCgov) September 29, 2020
Preventing and responding to COVID-19 on college campuses
30 Sep, 2020 | 09:47h | UTCPreventing and Responding to COVID-19 on College Campuses – JAMA